Accelerate Diagnostics Inc. diskutieren
Accelerate Diagnostics Inc.
WKN: A3ENW4 / Symbol: AXDX / Name: Accelerate Diagnostics / Aktie / Ausrüstung & Versorgung / Small Cap /
0,88 €
1,74 %
SecteurEquipement et technologie médicale avancés Agenda 07/11 Publication de résultats
Focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Nombre d'employés : 239 personnes.
(Zielkurs erreicht)
SecteurEquipement et technologie médicale avancés Agenda 07/11 Publication de résultats
Focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Nombre d'employés : 239 personnes.
(Vom Mitglied beendet)
Buy mit Kursziel 15,0
Buy Accelerate Diagnostics Inc.
Sell mit Kursziel 0,0
Buy Accelerate Diagnostics Inc.
Neueste Beiträge
WatchMen in Agba Acquisition Ltd. diskutieren, Agba Group Holding Ltd.